IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRLAB Therapeutics AB
Total Liabilities Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Total Liabilities
kr61.4m
CAGR 3-Years
40%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Total Liabilities
kr1.6B
CAGR 3-Years
85%
CAGR 5-Years
103%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Total Liabilities
kr503.7m
CAGR 3-Years
31%
CAGR 5-Years
28%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Total Liabilities
kr2.4B
CAGR 3-Years
77%
CAGR 5-Years
152%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Total Liabilities
kr24m
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Total Liabilities
kr34.7m
CAGR 3-Years
31%
CAGR 5-Years
9%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Total Liabilities?
Total Liabilities
61.4m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Total Liabilities amounts to 61.4m SEK.

What is IRLAB Therapeutics AB's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
38%

Over the last year, the Total Liabilities growth was 87%. The average annual Total Liabilities growth rates for IRLAB Therapeutics AB have been 40% over the past three years , 38% over the past five years .

Back to Top